Podcast

Pharmacy Focus: Psychedelic Pharmacy - Investigating Ketamine for Chronic Pain Management, Addiction Treatment

This month, we spoke with Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, about ketamine and the future of the opioid epidemic.

This month, we spoke with Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, about how investigative psychedelic treatments could help treat both chronic pain as well as addiction, and what this could mean for the future of the opioid epidemic.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit: JJAVA | stock.adobe.com
Related Content
Pharmacists’ Knowledge Gaps on Kratom: Building Competence for Patient Counseling
August 14th 2025

Pharmacists’ Knowledge Gaps on Kratom: Building Competence for Patient Counseling

Danielle Valletti, Assistant Editor
A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025
August 14th 2025

A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
The photo of large intestine is on the man's body against gray background, People With Stomach ache problem concept, Male anatomy | Image credit: eddows | stock.adobe.com
August 14th 2025

Beyond Pain Control: Understanding and Managing Opioid-Induced Constipation

Danielle Valletti, Assistant Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 14th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
Kratom (Mitragyna speciosa) capsules with powder and fresh leaf on wood background. | Image Credit: Paitoon | stock.adobe.com
August 14th 2025

FDA Moves to Restrict 7-OH Opioid Products

Danielle Valletti, Assistant Editor
Concept of Gabapentin write on paperwork isolated on Wooden Table | Image Credit: Syahrir | stock.adobe.com
August 14th 2025

Gabapentin Use Linked to Increased Dementia Risk in Patients With Chronic Back Pain

Danielle Valletti, Assistant Editor